|
|
 |
|
|
Parkinson's
Disease Pharmacotherapy Traineeship
Policies
& Guidelines
I.
Philosophy
Two of the objectives of the American Society of Consultant Pharmacists Foundation are
(1) to design, conduct, coordinate, and fund educational programs
and initiatives that enhance appropriate, effective, and safe
medication use in the senior population; and (2) to develop,
support, and promote the patient-centered principles and practice
of senior care pharmacy.
Accordingly, the ASCP Foundation conducts a post-graduate
traineeship in Parkinson’s disease pharmacotherapy. The
traineeship offers unique opportunities for pharmacists to
learn new skills,
sharpen existing skills, and
render new services.
The Parkinson’s Disease Pharmacotherapy Traineeship
is supported by an educational grant from Teva
Neuroscience and administered by the ASCP Foundation, 1321 Duke Street, Alexandria, Virginia 22314.
II.
Objectives
The primary objectives of the ASCP Foundation Parkinson’s
Disease Pharmacotherapy Traineeship are to prepare pharmacists to provide
a high level of pharmaceutical care to persons with Parkinson’s disease
and other neurologic disorders; to create pharmacist advocates for appropriate
care and treatment of persons with Parkinson’s disease in the settings
where they practice; and to positively impact the way pharmacists perceive
their role in the care and treatment of persons with Parkinson’s disease
and other movement disorders.
The full-time, four-and-a-half-day (Monday through Friday) traineeship
will provide individualized, intensive, didactic and experiential
training for selected practicing pharmacists. It will offer the
trainee an opportunity to observe and participate in the development
of treatment plans for persons with Parkinson’s disease
and other neurological disorders, including alternative clinical
diagnoses, control of medication adverse effects, drug interactions,
dementia and depression, adjustment of therapy, and the use of
adjunctive medications. The traineeship also offers the opportunity for pharmacists to work with an interdisciplinary team consisting of physicians, nurses, social workers, speech and physical therapists, caregivers, family members, and patients to positively impact the treatment outcome. Upon successful completion of the Parkinson’s Disease
Pharmacotherapy Traineeship, the participant will be able to:
1. Discuss the pathophysiology, differential diagnosis, and treatment of Parkinson’s
disease.
2. Describe possible therapeutic management strategies
for persons with Parkinson’s disease.
3. Identify and discuss
patient counseling issues concerning Parkinson’s disease
therapy.
4. Demonstrate the ability to evaluate drug therapy in
persons with Parkinson’s disease using the United Parkinson’s
Disease Rating Scale and Hoehn and Yahr staging.
5. Assess non-motor disability in patients with Parkinson’s disease.
6. Identify and
recommend treatment for management of problems frequently
encountered with long-term management of Parkinson’s
disease.
7. Assess the effect of
drug management changes on Parkinson’s
disease symptoms.
III.
Qualifications of the Traineeship Applicant
1. The applicant will be a graduate of a school or college
of pharmacy accredited by the Accreditation Council for Pharmacy Education. NOTE: Applicants from outside
the United
States and Canada should contact the ASCP Foundation
regarding this qualification.
2.
The applicant will actively
practice pharmacy and have at least two years experience
in pharmacy practice or comparable qualifications.
3.
The applicant will demonstrate strong
clinical knowledge and skills by citing clinical practice
experience.
4.
The applicant will have a demonstrated interest
in
the pharmacotherapy and overall treatment of Parkinson’s
disease.
5.
The applicant will be affiliated with health care facilities
or organizations able and willing to implement the results
of the
traineeship experience.
IV.
Application Procedure
-
The applicant must submit the completed application form
and the exhibits listed in item 2 below.
- The
following items are to be appended to
the application form, each clearly labeled
in the upper right-hand
corner, as indicated (Exhibit A, Exhibit B, Exhibit C):
Exhibit A. Curriculum vitae, which
must include the applicant’s
education, experience record in pharmacy practice (in
reverse chronological order, most recent first), and
any relevant publications,
presentations, and community service.
Exhibit B. A statement of not more
than three typed, double-spaced pages describing: (1)
why the applicant wants to participate in the
traineeship and the applicant’s expectations of the traineeship
experience; (2) nature and extent of professional or personal
involvement with persons with Parkinson’s disease and
other neurological disorders, caregivers, or family members;
(3) current level of clinical services provided by the applicant,
including total number of patients served, geographic distribution
(urban, rural, suburban), ethnic distribution (Black, White,
Hispanic, Asian/Pacific Islander, American Indian/Eskimo/Aleut),
and number of patients with Parkinson’s disease;
(4) special services or programs provided by the applicant;
(5) how the traineeship will enhance the pharmacy services
currently provided; and (6) how the results of the traineeship
experience will be incorporated into the applicant’s
practice.
Exhibit C*. A letter from the applicant’s
employer confirming support for the applicant’s
participation in the traineeship and willingness to implement
the results of the traineeship
experience. The letter should be addressed to the applicant
and signed by the chief executive officer, director of
pharmacy, clinical coordinator, or other appropriate
manager/supervisor
in the organization.
*If the applicant is self-employed, this exhibit may be
omitted.
V.
Selection Procedure
- Applications
will be reviewed and ranked by a selection panel appointed
by the ASCP Foundation. Decisions of the
selection panel will be final and without appeal.
- Selection will be based solely on information submitted
to the ASCP Foundation by the traineeship applicant.
- The
ASCP Foundation will notify all traineeship applicants
of
the outcome of their applications.
VI. Conduct and Administration of the Traineeship
1. The ASCP Foundation is the administrator of the
traineeship.
2.
The traineeship is awarded to an individual applicant.
3.
The trainee is responsible for expenses related to travel to the traineeship site, accommodations, meals, and incidentals.
4. The ASCP Foundation will coordinate hotel accommodations for the trainee, but the trainee is responsible for payment.
5. The trainee may be required to sign a waiver of liability appropriate
to the specific training sites.
6. The trainee will be required
to participate in all sessions of the program, complete a
program evaluation,
and submit two case consults (see section VII, item 1,
below).
VII. Requirements of the Trainee
In order to ensure the traineeship participants use
the skills and knowledge gained in some measurable way, the following
post-traineeship requirements must be met:
1. Traineeship participants are expected to write up and submit to the
ASCP Foundation two case consults for which they made recommendations
for treatment or interventions to improve care of patients with Parkinson’s
disease. The case consults will include: (1) description of the problem;
(2) treatment/intervention recommended and why; (3) goals of treatment/intervention
plan; (4) how staff, caregivers, family members, and patients were involved
in treatment decisions and monitoring; (5) expected outcomes; (6) how
outcomes were measured; and (7) actual outcomes and how and why they
differed from
the expected outcomes. The format for the case consults will be distributed
after the traineeship.
2. Traineeship participants are expected to become involved with their
local Parkinson’s disease support group by volunteering to speak
at meetings, write articles for newsletters, or participate in other ways
to meet a specific
need within their community.
3. Traineeship participants will have the opportunity to participate in
the ASCP Foundation Traineeship Network by attending meetings and educational
programs at the ASCP Midyear Conference and Annual Meeting, and by subscribing
to the Foundation’s Traineeship Network E-Mail List Server. Traineeship
participants may be asked to participate in educational programs at ASCP
meetings and assist the ASCP Foundation in promoting the traineeship.
VIII. Continuing Education
To
receive continuing education credit, trainees must participate
in all
sessions
of the program
and
complete
an evaluation at the conclusion of the traineeship. Statements
of continuing education credit will be mailed to trainees
within one month after successful completion of the program
and receipt of evaluation.
 ® |
The
American Society of Consultant Pharmacists is accredited by
the Accreditation Council for Pharmacy Education as a provider
of continuing pharmacy education. This is program number 203-000-08-101-L01. |
ASCP Foundation
The ASCP Foundation is the research and education affiliate
of the American Society of Consultant Pharmacists. The mission
of the ASCP Foundation is to improve the health and well-being
of older persons through appropriate, effective, and safe medication
use. The ASCP Foundation provides leadership, innovation, and
expertise in medicines and aging to seniors and those who care
for them. The unique focus of the ASCP Foundation is the development,
integration, and application of knowledge regarding medication
use in the senior population and the practice of senior care
pharmacy to optimize health care outcomes.
|
|
  |
|
| |
|
| |
|
|
